Anemia and MDS, What You Need To Know

Name: Anemia and MDS, What You Need To Know
Start: 2023-10-03T15:00:00-04:00
End: 2023-10-03T16:00:00-04:00

Anemia and MDS, What You Need To Know

Adult MDS

Oct 03, 2023 / 03:00PM - 04:00PM EDT

Event Description

Anemia is one of the largest problems MDS patients face. What exactly is anemia? What does it have to do with MDS? How do you treat it? How do you live with it?

MDS specialist Dr. Douglas Tremblay researches anemia and will help us answer these questions.

Schedule & Agenda

Introduction

1:00 PM

Mary Arnett

Mary introduces the agenda for the event and featured speaker Douglas Tremblay, MD.

1 :00 PM

Mary Arnett

Introduction

Mary introduces the agenda for the event and featured speaker Douglas Tremblay, MD.

Presentation

1:05 PM

Douglas Tremblay, MD

Dr. Douglas Tremblay researches anemia, and will help answer the questions: What exactly is anemia? What does it have to do with MDS? How do you treat it? and How do you live with it?

1 :05 PM

Douglas Tremblay, MD

Presentation

Dr. Douglas Tremblay researches anemia, and will help answer the questions: What exactly is anemia? What does it have to do with MDS? How do you treat it? and How do you live with it?

Questions and Answers

1:40 PM

Audience

Type your questions in the chat and Dr. Tremblay will answer them!

1 :40 PM

Audience

Questions and Answers

Type your questions in the chat and Dr. Tremblay will answer them!

Speakers & Moderators

Mary Arnett

Salt Lake City, Utah

Mary joined HealthTree as the HealthTree for MDS Program Manager in 2022. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for MDS patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio

Douglas Tremblay, MD

New York, New York

Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.

Read Bio